REGULATION OF CYCLOOXYGENASE-2 AND ENDOGENOUS CYTOKINE EXPRESSION BY BACTERIAL LIPOPOLYSACCHARIDE THAT ACTS IN SYNERGY WITH C-KIT LIGAND AND FC-EPSILON RECEPTOR-I CROSS-LINKING IN CULTURED MAST-CELLS
Tc. Moon et al., REGULATION OF CYCLOOXYGENASE-2 AND ENDOGENOUS CYTOKINE EXPRESSION BY BACTERIAL LIPOPOLYSACCHARIDE THAT ACTS IN SYNERGY WITH C-KIT LIGAND AND FC-EPSILON RECEPTOR-I CROSS-LINKING IN CULTURED MAST-CELLS, Cellular immunology, 185(2), 1998, pp. 146-152
Emerging evidence has suggested the pivotal role of mast cells in a ho
st defense against bacterial infection. In this paper, we report that
bacterial lipopolysaccharide (LPS) is a potent enhancer of the cytokin
e-and IgE-dependent delayed responses of IL-3-dependent mouse bone mar
row-derived cultured mast cells (BMMC). LPS, although showing minimal
effects, significantly augmented the c-kit ligand (KL)- or IgE-depende
nt expression of cyclooxygenase (COX)-2 and the attendant delayed PGD(
2) generation, with IL-10 and IL-4 acting as potentiating and inhibito
ry cytokines, respectively. The COX-2-inducing activity of LPS was mim
icked by exogenous IL-1 beta. Assessment of endogenous cytokine induct
ion revealed that IL-1 beta expression was stimulated by either LPS or
exogenous IL-1 beta. IL-6 expression occurred in parallel with COX-2
expression. IL-10 expression, which lagged behind COX-2 expression, de
pended on exogenous IL-10, but not on LPS and IL-1 beta. Thus, LPS and
IL-1 beta exhibited similar biological activities in terms of COX-2 a
nd endogenous cytokine expression. However, adding an antibody against
the type I IL-1 receptor to BMMC, which abrogated the effects of IL-1
beta, failed to neutralize the effects of LPS. These results suggest
that LPS activates BMMC through the signal transduction pathway shared
with exogenous IL-1 beta, rather than exerting its action indirectly
via the production of endogenous IL-1 beta. (C) 1998 Academic Press.